Angiotensin-(3-4) counteracts the Angiotensin II inhibitory action on renal Ca 2+-ATPase through a cAMP/PKA pathway

Regulatory Peptides

Volumn 177, Issue 1-3, 2012, Pages 27-34

  Axelband, Flavia ^a,b   Dias, Juliana ^a,b   Miranda, Filipe ^a,b   Ferrão, Fernanda M ^a,b   Reis, Rosana I ^c   Costa Neto, Claudio M ^c   Lara, Lucienne S ^a,b   Vieyra, Adalberto ^a,b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Instituto Nacional de Ciencia e Tecnologia em Biologia Estrutural e Bioimagem   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Ang (3 4); AT (1 7)R(MAS); AT 1R; AT 2R; AT 4R; BSA; CAMP; CGP4211A; CHAPS; Cyclic AMP dependent protein kinase; Db cAMP; DMEM; HEPES; IBMX; Kidney cells; Losartan; PD123319; PKA; PKAi; PKC; Plasma membrane Ca 2+ ATPase; Proximal tubule basolateral membranes; SDS PAGE; TBS; TCA; TRIS

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN DERIVATIVE; ANGIOTENSIN II; ANGIOTENSIN[3-4]; BUCLADESINE; CHOLERA TOXIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BINDING ASSAY; BINDING SITE; CELL TYPE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RECEPTOR AFFINITY; RECEPTOR BINDING; SHEEP;

ALLOSTERIC REGULATION; ANGIOTENSIN II; ANGIOTENSIN II TYPE 2 RECEPTOR BLOCKERS; ANIMALS; BINDING, COMPETITIVE; CALCIUM-TRANSPORTING ATPASES; CELL MEMBRANE; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENZYME ACTIVATION; ENZYME ASSAYS; HEK293 CELLS; HUMANS; IMIDAZOLES; IMMUNOPRECIPITATION; KIDNEY TUBULES, PROXIMAL; LOSARTAN; OLIGOPEPTIDES; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN CONFORMATION; PYRIDINES; RECEPTOR, ANGIOTENSIN, TYPE 2; SHEEP; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 84862754576     PISSN: 01670115     EISSN: 18731686     Source Type: Journal    
DOI: 10.1016/j.regpep.2012.04.004     Document Type: Article

References (40)

1. Kramkowski K., Mogielnicki A., Buczko W. The physiological significance of the alternative pathways of angiotensin II production. J Physiol Pharmacol 2006, 57:529-539.
2. Santos R.A., Simões-e-Silva A.C., Maric C., Silva D.M.R., Machado R.P., Buhr I., Heringer-Walther S., Pinheiro S.V.B., Lopes M.T., Bader M., Mendes E.P., Lemos V.S., Campagnole-Santos M.J., Schultheiss H.P., Speth R., Walther T. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor MAS. Proc Natl Acad Sci U S A 2003, 100:8258-8263.
3. Haulica I., Petrescu G., Slatineanu S.M., Bild W., Mihaila C.N., Ionita T. New bioactive angiotensins formation pathways and functional involvements. Rom J Intern Med 2004, 42:27-40.
4. Axelband F., Dias J., Miranda F., Ferrão F.M., Barros N.M., Carmona A.K., Lara L.S., Vieyra A. A scrutiny of the biochemical pathways from Ang II to Ang-(3-4) in renal basolateral membranes. Regul Pept 2009, 158:47-56.
5. Saito Y., Wanezaki K., Kawato A., Imayasu S. Structure and activity of angiotensin I converting enzyme inhibitory peptides from sake and sake lees. Biosci Biotechnol Biochem 1994, 58:1767-1771.
6. Matsufuji H., Matsui T., Ohshige S., Kawasaky T., Osajima K., Osajima Y. Antihypertensive effects of angiotensin fragments in SHR. Biosci Biotechnol Biochem 1995, 59:1398-1401.
7. Axelband F., Assunção-Miranda I., de Paula I.R., Ferrão F.M., Dias J., Miranda A., Miranda F., Lara L.S., Vieyra A. Ang-(3-4) suppresses inhibition of renal plasma membrane calcium pump by Ang II. Regul Pept 2009, 155:81-90.
8. 2-receptor antagonists. Regul Pept 2005, 127:151-157.
9. Du Z., Ferguson W., Wang T. Role of PKC and calcium in modulation of effects of angiotensin II on sodium transport in proximal tubule. Am J Physiol 2003, 284:F688-F692.
10. 2+-ATPase from kidney-proximal tubule cells with protein kinase A as an intermediate. J Biol Chem 2007, 282:24599-24606.
11. +-ATPase activity in Madin-Darby canine kidney epithelial (MDCK) cells. Pfluegers Arch 1992, 420:269-274.
12. +-ATPase. Biochim Biophys Acta 2011, 1808:1684-1700.
13. +-ATPase. Arch Biochem Biophys 2010, 496:117-122.
14. 32P)-nucleoside triphosphates with high specific activity. Genes and antigenes of parasites, a laboratory manual proceedings 1983, 146-157. Editora Fundação Oswaldo Cruz, Rio de Janeiro.
15. Gether U., Johansen T.E., Schwartz T.W. Chimeric NK1 (substance P)/NK3 (neurokinin B) receptors - identification of domains determining the binding specificity of tachykinin. J Biol Chem 1993, 268:7893-7898.
16. + extrusion in cells from guinea pig kidney cortex slices. Pfluegers Arch 1970, 316:1-25.
17. 2+)-ATPase through a pathway sensitive to cholera toxin and sphingosine. Eur J Biochem 1999, 263:71-78.
18. Valverde R.H., Britto-Borges T., Lowe J., Einicker-Lamas M., Mintz E., Cuillel M., Vieyra A. Two serine residues control sequential steps during catalysis of the yeast copper ATPase through different mechanisms that involve kinase-mediated phosphorylations. J Biol Chem 2011, 286:6879-6889.
19. Simonds W.F. G protein regulation of adenylate cyclase. Trends Pharmacol Sci 1999, 20:66-73.
20. Vieira-Filho L.D., Lara L.S., Silva P.A., Santos F.T., Luzardo R., Oliveira F.S., Paixão A.D., Vieyra A. Placental malnutrition changes the regulatory network of renal Na-ATPase in adult rat progeny: reprogramming by maternal α-tocopherol during lactation. Arch Biochem Biophys 2011, 505:91-97.
21. Mogi M., Iwai M., Horiuchi M. New insights into the regulation of angiotensin receptors. Curr Opin Nephrol Hypertens 2009, 18:138-143.
22. 2 receptor-interacting proteins. Trends Endocrinol Metab 2010, 21:684-690.
23. Matsui T., Hayashi A., Tamaya K., Matsumoto K., Kawasaki T., Murakami K., Kimoto K. Depressor effect induced by dipeptide, Val-Tyr, in hypertensive transgenic mice is due, in part, to the suppression of human circulating renin-angiotensin system. Clin Exp Pharmacol Physiol 2003, 30:262-265.
24. Pentzien A.K., Meisel H. Transepithelial transport and stability in blood serum of angiotensin-I-converting enzyme inhibitory dipeptides. Z Naturforsch C 2008, 63:451-459.
25. Wang Z., Zhang S., Jin H., Wang W., Huo J., Zhou L., Wang Y., Feng F., Zhang L. Angiotensin-I-converting enzyme inhibitory peptides: chemical feature based pharmacophore generation. Eur J Med Chem 2011, 46:3428-3433.
26. Matsui T., Tamaya K., Matsumoto K., Osajima Y., Uezono K., Kawasaki T. Plasma concentrations of angiotensin metabolites in young male normotensive and mild hypertensive subjects. Hypertens Res 1999, 22:273-277.
27. Matsui T., Imamura M., Oka H., Osajima K., Kimoto K., Kawasaki T., Matsumoto K. Tissue distribution of antihypertensive dipeptide, Val-Tyr, after its single oral administration to spontaneously hypertensive rats. J Pept Sci 2004, 10:535-545.
28. James P.H., Pruschy M., Vorherr T.E., Penniston J.T., Carafoli E. Primary structure of the cAMP-dependent phosphorylation site of the plasma membrane calcium pump. Biochemistry 1989, 28:4253-4258.
29. 2+ ATPase of animal cells: structure, function and regulation. Arch Biochem Biophys 2008, 476:65-74.
30. Carafoli E. Biogenesis: plasma membrane calcium ATPase: 15years of work on the purified enzyme. FASEB J 1994, 8:993-1002.
31. 2+ waves preferentially originate at specific loci in caveolin-rich cell edges. Proc Natl Acad Sci U S A 1998, 95:5009-5014.
32. Isshiki M., Anderson R.G.W. Calcium signal transduction from caveolae. Cell Calcium 1999, 26:201-208.
33. 2+ pump from proximal kidney tubules is exclusively localized and active in caveolae. FEBS Lett 2004, 576:31-35.
34. Zhuo J.L., Li X.C. New insights and perspectives on intrarenal renin-angiotensin system: focus on intracrine/intracellular angiotensin II. Peptides 2011, 32:1551-1565.
35. Guimarães P.B., Alvarenga É.C., Siqueira P.D., Paredes-Gamero E.J., Sabatini R.A., Morais R.L., Reis R.I., Santos E.L., Teixeira L.G., Casarini D.E., Martin R.P., Shimuta S.I., Carmona A.K., Nakaie C.R., Jasiulionis M.G., Ferreira A.T., Pesquero J.L., Oliveira S.M., Bader M., Costa-Neto C.M., Pesquero J.B. Angiotensin II binding to angiotensin I-converting enzyme triggers calcium signaling. Hypertension 2011, 57:965-972.
36. Navar L.G., Nishiyama A. Why are angiotensin concentrations so high in the kidney?. Curr Opin Nephrol Hypertens 2004, 13:107-115.
37. 1 receptor-mediated signaling responses in proximal tubules of angiotensin II-induced hypertensive rats. Kidney Int 2011, 80:620-632.
38. Valverde R.H., Morin I., Lowe J., Mintz E., Cuillel M., Vieyra A. Cyclic AMP-dependent protein kinase controls energy interconversion during the catalytic cycle of the yeast copper-ATPase. FEBS Lett 2008, 582:891-895.
39. Wang L., Martin B., Brenneman R., Luttrell L.M., Maudsley S. Allosteric modulators of G protein-coupled receptors: future therapeutics for complex physiological disorders. J Pharmacol Exp Ther 2009, 331:340-348.
40. Schwartz T.W., Holst B. Allosteric enhancers, allosteric agonists and ago-allosteric modulators: where do they bind and how do they act?. Trends Pharmacol Sci 2007, 28:366-373.